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Synergistic activation of SAPK1/JNK1 by two MAP kinase
kinases in vitro
Sean Lawler*, Yvonne Fleming*, Michel Goedert† and Philip Cohen*
Mitogen-activated protein kinases (MAPKs) mediate
many of the cellular effects of growth factors, cytokines
and stress stimuli. Their activation requires the
phosphorylation of a threonine and a tyrosine residue
located in a Thr–X–Tyr motif (where X is any amino
acid) [1]. This phosphorylation is catalysed by MAPK
kinases (MKKs), which are all thought to be ‘dual
specificity’ enzymes that phosphorylate both the
threonine and the tyrosine residue of the Thr–X–Tyr
motif [2]. Here, we report that the MAPK family member
known as stress-activated protein kinase-1c (SAPK1c,
also known as JNK1) [3] is activated synergistically in
vitro by MKK4 ([4–6]; also called SKK1 and JNKK1) and
MKK7 ([7–9]; also called SKK4 and JNKK2). We found
that MKK4 had a preference for the tyrosine residue,
and MKK7 for the threonine residue, within the
Thr–X–Tyr motif. These observations suggest that the
full activation of SAPK1c in vivo may sometimes require
phosphorylation by two different MKKs, providing the
potential for integrating the effects of different
extracellular signals. They also raise the possibility that
other MAPK family members may be activated by two
or more MKKs and that some MKKs may have gone
undetected because they phosphorylate the tyrosine
residue only, and therefore do not induce any activation
unless the threonine has first been phosphorylated by
another MKK.
Addresses: *MRC Protein Phosphorylation Unit, Department of
Biochemistry, University of Dundee, MSI/WTB Complex, Dundee DD1
5EH, UK. †MRC Laboratory of Molecular Biology, Hills Road,
Cambridge CB2 2QH, UK.
Correspondence: Philip Cohen
E-mail: pcohen@bad.dundee.ac.uk.
Received: 26 August 1998
Revised: 28 October 1998
Accepted: 13 November 1998
Published: 14 December 1998
Current Biology 1998, 8:1387–1390
http://biomednet.com/elecref/0960982200801387
© Current Biology Ltd ISSN 0960-9822
Results and discussion
MKK4 and MKK7 that had been activated by MEKK1 (a
MAPK kinase kinase) were diluted appropriately to
produce a small activation of SAPK1c after a 20 minute
incubation. When MKK4 and MKK7 were combined, the
rate and extent of activation of SAPK1c increased eight-
fold (Figures 1a and 2a), although the incorporation of
phosphate into SAPK1c was not even doubled
(Figure 1b). These results suggested that MKK4 and
MKK7 were likely to be acting synergistically by phospho-
rylating different sites on SAPK1c and this was confirmed
by phosphoamino-acid analysis. Thus, SAPK1c incubated
with low levels of MKK4 was phosphorylated mostly on
tyrosine, whereas SAPK1c incubated with MKK7 was
largely phosphorylated on threonine (Figure 2c).
If the concentration of MKK4 was increased from 0.05 to
0.2 µM and the incubation time extended from 20 to
60 minutes, SAPK1c activation was increased eightfold
(compare Figure 2a and Figure 2b), and substantial threo-
nine phosphorylation could now be detected in addition to
tyrosine phosphorylation (Figure 2d). Increasing the
MKK7 concentration from 0.4 to 0.8 µM and the incuba-
tion time from 20 to 60 minutes (or longer) increased
SAPK1c activation only about threefold and tyrosine phos-
phorylation remained low (Figure 2d). Under these condi-
tions, the combined addition of MKK7 and MKK4 did not
produce much further activation over that obtained with
MKK4 alone (Figure 2b).
Figure 1
MKK4 and MKK7 activate SAPK1c synergistically. MKK4 and MKK7
were activated by MEKK1 (see Materials and methods). (a) SAPK1c
(2 µM) was incubated for the indicated times with MgATP and 0.05µM
MKK4, 0.4 µM MKK7 or 0.05 µM MKK4 plus 0.4 µM MKK7. The
results of a single experiment are shown, but similar results were
obtained in four separate experiments. (b) The experiment was carried
out as in (a), except that [γ-32P]ATP replaced unlabelled ATP, and
phosphorylation of SAPK1 was measured instead of its activity. There
was no phosphorylation or activation in the absence of MKK4 or MKK7.
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To identify the sites of phosphorylation, 32P-labelled
SAPK1c preparations were digested with trypsin and the
resulting phosphopeptides resolved on a C18 column.
SAPK1c phosphorylated by MKK4 generated a major
phosphopeptide eluting at 20.6% acetonitrile (peptide 2)
and a minor phosphopeptide at 19.6% acetonitrile
(peptide 1; Figure 3a). In contrast, peptide 3 (eluting at
21.3% acetonitrile) was the major phosphopeptide after
phosphorylation by MKK7, whereas peptide 2 was present
only in trace amounts (Figure 3b). When SAPK1c was
phosphorylated in the presence of both MKK4 and
MKK7, peptides 1, 2 and 3 were all present, peptide 1
being more prominent than after phosphorylation by
MKK4 alone and peptide 3 being far less prominent than
after phosphorylation by MKK7 (Figure 3c).
A combination of phosphoamino-acid analysis (data not
shown) and Edman sequencing (Figure 3d–f) revealed that
peptides 1, 2 and 3 were differentially phosphorylated forms
of the same 15-residue tryptic peptide encompassing the
Thr–Pro–Tyr motif of SAPK1c. Peptide 1 contained phos-
phothreonine and phosphotyrosine, and 32P-radioactivity
was released after the ninth and eleventh cycles of Edman
degradation (Figure 3d). This corresponds to Thr183 and
Tyr185 with the tryptic cleavage occurring at the Arg–Thr
bond between residues 174 and 175. Peptide 2 contained
phosphotyrosine only and was phosphorylated at Tyr185
(Figure 3e), whereas peptide 3 contained phosphothreonine
only and was phosphorylated at Thr183 (Figure 3f). These
results confirm that MKK4 phosphorylates Tyr185 much
faster than Thr183 and that MKK7 phosphorylates Thr183
much more rapidly than Tyr185. MKK7, however, clearly
does phosphorylate Tyr185 at a low rate.
The preference of MKK4 for Tyr185 has been noted pre-
viously by others [4], who suggested that the slower phos-
phorylation of Thr183 might be an autophosphorylation
event catalysed by SAPK1 itself after Tyr185 had been
phosphorylated by MKK4. We found, however, that the
level of threonine phosphorylation was not significantly
affected by mutating the Asp169 residue to Ala, which
generates a catalytically inactive SAPK1c (see Supplemen-
tary material published with this paper on the internet).
Thus, MKK4 can phosphorylate SAPK1c at Thr183.
SAPK1 that has been maximally activated by coexpression
with MKK4 in Escherichia coli can be completely inacti-
vated by treatment with protein phosphatase 2A (PP2A),
but is only 90% inactivated by treatment with the protein
tyrosine phosphatase PTP1B [10]. This suggests that
Tyr185 phosphorylation alone is insufficient for activation,
and that SAPK1 phosphorylated specifically at Thr183
may be 10% as active as the doubly phosphorylated
enzyme. This conclusion is supported by our finding that
SAPK1c that is activated by MKK4 was inactivated
90–95% by treatment with PTP1B, whereas SAPK1c acti-
vated by MKK7 was inactivated by only 40% when treated
with PTP1B in parallel experiments. In contrast, PP2A
decreased SAPK1c by more than 90%, irrespective of
which MKK was used for activation (data not shown).
The above results implied that the phosphorylation state
of SAPK1c might be critical in determining which activa-
tors of this enzyme can be detected biochemically. The
results in Figure 4 demonstrate that this is indeed the
case. When MKK4 and MKK7 were immunoprecipitated
from the lysates of an interleukin-1 (IL-1)-responsive
human oral epidermal carcinoma cell line (KB cells) previ-
ously exposed to ultraviolet (UV) radiation, MKK7 was
the only activator of SAPK1c detected when the assays
were carried out using SAPK1c that was first phosphory-
lated with low concentrations of MKK4 (Figure 4a). Con-
versely, MKK4 was the only activator detected when the
assays were performed with SAPK1c partially phosphory-
lated with low concentrations of MKK7 (Figure 4b).
Under the same assay conditions, MKK4 and MKK7
could barely be detected when unphosphorylated
SAPK1c was used as a substrate. When the same experi-
ments were carried out using lysates from KB cells that
1388 Current Biology, Vol 8 No 25
Figure 2
Activation and phosphorylation of SAPK1c by MKK4 and MKK7.
(a) SAPK1c was incubated for 20 min with unlabelled MgATP and
0.05 µM MKK4, 0.4 µM MKK7, or 0.05 µM MKK4 plus 0.4 µM MKK7
(MKK4/7). (b) As in (a), except that MKK4 and MKK7 were increased
to 0.2 µM and 0.8 µM, respectively, and the incubation time was
lengthened to 60 min. (c) As in (a), except that SAPK1c was incubated
with [γ-32P]ATP and MKK4 and/or MKK7 and, after SDS–PAGE and
transfer to nitrocellulose membranes, the SAPK1c band was excised
and its phosphoamino-acid content analysed [16]. (d) As in (c), except
that SAPK1c was activated as in (b). Abbreviations are: pS,
phosphoserine; pT, phosphothreonine; pY, phosphotyrosine.
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had been stimulated with IL-1 (Figure 4c,d), MKK7 was
detected in an assay using SAPK1c partially phosphory-
lated with low concentrations of MKK4, but not with any
other substrate (Figure 4c). In contrast, MKK4 could not
be detected irrespective of the phosphorylation state of
the substrate (Figure 4d).
The results presented in Figure 4 are consistent with
previous work from this [8] and other [9,11] laboratories
which showed that, while MKK4 and MKK7 are both
activated in response to stress stimuli, only MKK7 is
activated by the proinflammatory cytokines IL-1 and
tumour necrosis factor (TNF) in several mammalian
cells and tissues. This raises the question of whether
further IL-1/TNF-activated MKKs exist that phosphory-
late SAPK1 isoforms at Tyr185. Indeed, activators of
SAPK1 that are induced by IL-1/TNF and are chromato-
graphically distinct from MKK4 and MKK7 have been
partially purified, but their specificity for Thr183 and
Tyr185 has not been reported and they have not yet
been cloned [9,12,13].
Embryonic fibroblasts isolated from mice lacking MKK4
are severely impaired in the activation of SAPK1 after
stimulation by IL-1 or TNF [14], in apparent conflict with
the work cited above, which showed that MKK7 (and not
MKK4) is activated by these proinflammatory cytokines in
other cells and tissues. The MKK4–/– fibroblasts, however,
were also severely impaired in their ability to activate
MKK3 or MKK6 or their downstream target SAPK2a (also
known as p38) after stimulation with IL-1/TNF (but not
after exposure to osmotic shock). These observations
suggest that MKK4 may be needed for the synthesis of a
protein required to couple IL-1/TNF to the activation of
MKK3/MKK6. It will clearly be important to examine
whether the activation of MKK7 (or its synthesis) is
impaired in MKK4–/– mice.
It was essential to remove the histidine6 (His6) tag and
‘linker’ sequence from the amino terminus of SAPK1c
fusion proteins to perform the experiments described in
this paper (see Materials and methods). If this was not
done, the His6–SAPK1c fusion protein became phospho-
rylated equally at tyrosine and threonine after incubation
with MKK7. Remarkably, however, phosphopeptide
mapping and amino-acid sequencing revealed that MKK7
had not phosphorylated Tyr185, but had phosphorylated a
tyrosine residue in the linker sequence before the start of
the SAPK1c protein (data not shown). This tyrosine
residue lies in the sequence Arg–Asp–Asp–Leu–Tyr–
Asp–Asp–Asp–Asp. Thus, although MKK7 preferentially
phosphorylates bacterially expressed SAPK1c at Thr183,
it is intrinsically a dual-specificity protein kinase, like
other MKKs. This raises the intriguing possibility that a
protein(s) may exist that enhances the ability of MKK7 to
phosphorylate SAPK1 at Tyr185. A candidate could be the
Jun N-terminal kinase (JNK)-interacting protein 1 (JIP1),
which interacts with MKK7 and SAPK1 and is reported to
enhance the activation of SAPK1 by MKK7 in cotransfec-
tion experiments [15]. 
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Figure 3
Tryptic phosphopeptide mapping of SAPK1c.
(a–c) SAPK1c was phosphorylated with
[γ-32P]ATP and MKK4 and/or MKK7 as in
Figure 2a and, after SDS–PAGE, the bands
corresponding to SAPK1c were excised,
extracted, oxidised with performic acid,
digested with trypsin and chromatographed
on a Vydac C18 column equilibrated in 0.1%
trifluoroacetic acid as in [16]. The solid lines
show 32P radioactivity and the dashed lines
the acetonitrile gradient. (d–f) Peptides 1, 2
and 3 from (a–c) were subjected to solid-
phase sequencing to identify the sites of
phosphorylation and also (after further
purification) to conventional gas-phase
sequencing [17]. The figure shows the results
for peptide 1 from (c), peptide 2 from (a), and
peptide 3 from (b). The three peptides from
(a–c) were sequenced and gave identical
results. The amino-acid symbols shown are in
the single-letter amino-acid code.
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Materials and methods
Expression and purification of recombinant fusion proteins
Recombinant glutathione-S-transferase (GST)–MKK4, GST–MKK7,
GST–ATF2(19–96), His6–MEKK and His6–SAPK1c were expressed
in E. coli and purified as described [8]. Asp169 of SAPK1c was
mutated to Ala by site-directed mutagenesis to create a catalytically
inactive mutant. The SAPK1 sequence was preceded by 41 residues
comprising the sequence Met–Arg–Gly–Ser followed by six histidine
residues and 31 residues of a linker sequence. Cleavage with enteroki-
nase (Invitrogen) according to the manufacturer’s recommendations
removed the Met–Arg–Gly–Ser sequence, the His6 tag and 21
residues of the linker sequence. The proteinase was removed by incu-
bation with soybean trypsin inhibitor agarose (Sigma), and any
uncleaved protein and the cleaved His6 tag were removed using nickel-
nitrilotriacetate (NTA) agarose (Qiagen). The unbound protein was then
passed through a Spin-X filter (Costar) and dialysed overnight against
50 mM TrisHCl pH 7.5, 0.1 mM EGTA, 0.1% (v/v) 2-mercaptoethanol,
0.03% (m/v) Brij35, 50% (v/v) glycerol, and stored unfrozen at –20°C
at a concentration of 1 mg/ml. GST–MKK4 and GST–MKK7 were acti-
vated by treatment with His6–MEKK [8].
Protein kinase assays
The rate of SAPK1c activation by GST–MKK4 and/or GST–MKK7 was
measured at 30°C in a 25 µl reaction containing 2 µM His6–SAPK1,
50 mM TrisHCl pH 7.5, 0.1% (v/v) 2-mercaptoethanol, 0.1 mM EGTA,
unlabelled 0.1 mM ATP and 10 mM magnesium acetate. Activated
GST–MKK4 and/or GST–MKK7 were added (or replaced by buffer in
control incubations) and, at various times, a 5 µl aliquot was withdrawn
and added to a SAPK1c/JNK1γ assay (50 µl final volume) containing
3 µM GST–ATF2(19–96), 50 mM Tris/HCl pH 7.5, 0.1 mM EGTA,
0.1% (v/v) 2-mercaptoethanol, 10 mM magnesium acetate and 0.1 mM
[γ-32P]ATP (500,000 cpm/nmol). After 5 min at 30°C, the reaction was
terminated by spotting 40 µl on to Whatman P81 phosphocellulose
paper and immersion in 75 mM phosphoric acid. The papers were
washed, dried and counted [8]. Under these conditions the rate of acti-
vation of SAPK1c was linear with time and enzyme concentration up to
0.1 µM MKK4 and 1 µM MKK7. One unit of SAPK1 was that amount
which incorporated 1 nmol phosphate into GST–ATF2 in 1 min.
Supplementary material
A figure showing that MKK4 phosphorylates both wild-type SAPK1c
and a catalytically inactive Asp169→Ala SAPK1c mutant at Thr183 as
well as at Tyr185 is published with this paper on the internet.
Acknowledgements
This work was supported by the UK Medical Research Council (P.C. and
M.G.), The Royal Society (P.C.) and the Louis Jeantet Foundation (P.C.).
References
1. Payne DM, Rossomando AJ, Martino P, Erickson AK, Her JH,
Shabanowitz J, et al.: Identification of the regulatory
phosphorylation sites in pp42/mitogen-activated protein kinase
(MAP kinase). EMBO J 1991, 10:885-892.
2. Nakielny S, Cohen P, Wu J, Sturgill T: MAP kinases activator from
insulin-stimulated skeletal muscle is a protein threonine/tyrosine
kinase. EMBO J 1992, 11:2123-2129.
3. Cohen P: The search for physiological substrates of MAP and SAP
kinases in mammalian cells. Trends Cell Biol 1997, 7:353-361.
4. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, et
al.: Role of SAPK/ERK kinase-1 in the stress-activated pathway
regulating transcription factor c-jun. Nature 1994, 372:794-798.
5. Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, et al.:
Independent human MAP-kinase signal transduction pathways
defined by MEK and MKK isoforms. Science 1995, 267:682-685.
6. Lin A, Minden A, Martinetto H, Claret FX, Lange-Carter C, Mercurio F,
et al.: Identification of a dual specificity kinase that activates the
Jun kinases and p38-Mpk2. Science 1995 268:286-290.
7. Tournier C, Whitmarsh A, Cavanagh J, Barrett T, Davis RJ: Mitogen-
activated protein kinase kinase 7 is an activator of the c-jun NH2-
terminal kinase. Proc Natl Acad Sci USA 1997, 94:7337-7342.
8. Lawler S, Cuenda A, Goedert M, Cohen P: SKK4, a novel activator
of stress-activated protein kinase-1. FEBS Lett 1997, 414:153-158.
9. Moriguchi T, Toyoshima F, Masuyama N, Hanafusa H, Gotoh Y,
Nishida E: A novel SAPK/JNK kinase, MKK7, stimulated by
TNFalpha and cellular stresses. EMBO J 1997, 16:7045-7053.
10. Knokhlatchev A, Xu S, English J, Wu P, Schaefer E , Cobb MH:
Reconstitution of mitogen-activated protein kinase phosphorylation
cascades in bacteria. J Biol Chem 1997, 272:11057-11062.
11. Finch A, Holland P, Cooper J, Saklatvala J, Kracht M: Selective
activation of JNK/SAPK by interleukin-1 in rabbit liver is mediated
by MKK7. FEBS Lett 1997, 418:144-148.
12. Meier R, Rouse J, Cuenda A, Nebreda AR, Cohen P: Cellular
stresses and cytokines activate multiple mitogen-activated-
protein kinase kinase homologues in PC12 and KB cells. Eur J
Biochem 1996, 236:796-805.
13. Cuenda A, Dorow D: Differential activation of stress-activated
protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the
mixed-lineage kinase-2 and mitogen-activated protein kinase
kinase (MKK) kinase-1. Biochem J 1998, 333:11-15.
14. Ganiatsas S, Kwee L, Fujiwara Y, Perkins A, Ikeda T, Labow MA, Zon
LI: SEK1 deficiency reveals mitogen-activated protein kinase
cascade crossregulation and leads to abnormal hepatogenesis.
Proc Natl Acad Sci USA 1998, 95:6881-6886.
15. Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ: A
mammalian scaffold complex that selectively mediates MAP
kinase activation. Science 281:1671-1674.
16. Alessi DR, Andjelkovic M, Caudwell FB, Cron P, Morrice N, Cohen P,
et al.: Mechanism of activation of protein kinase B by insulin and
IGF-1. EMBO J 1996 15:6541-6551.
17. Stokoe D, Campbell DG, Nakielny S, Hidaka H, Leevers SJ, Marshall
C, et al.: MAPKAP kinase-2; a novel protein kinase activated by
mitogen-activated protein kinase. EMBO J 1992, 11:3985-3994.
1390 Current Biology, Vol 8 No 25
Figure 4
Detection of the activators of SAPK1c in KB cell extracts depends on
the phosphorylation state of SAPK1c. KB cells were either
(a,b) exposed to UV-C radiation (60 J/cm2) and then incubated for a
further 30 min at 37°C, or (c,d) stimulated for 15 min with 20 ng/ml 
IL-1. The cells were then lysed as described [16] and MKK7 (a,c) or
MKK4 (b,d) immunoprecipitated from 250 µg cell lysate [8] and
assayed with unphosphorylated SAPK1c (white bars), SAPK1c
previously phosphorylated for 5 min with MKK4 as in Figure 1a (grey
bars), or SAPK1c previously phosphorylated for 5 min with MKK7 as in
Figure 1a (blue bars). The results are shown ± SEM for two dishes of
cells, each assayed in duplicate. Similar results were obtained in
several different experiments.
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S1Supplementary material
Figure S1
MKK4 phosphorylates both (a) wild-type SAPK1c and (b) a
catalytically inactive Asp169→Ala SAPK1c mutant at Thr183 as well
as at Tyr185. Phosphorylation was carried out using high
concentrations of MKK4 as described in Figure 2b.
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